Cancer Therapy Interactions With Foods and Dietary Supplements (PDQ) – health professional version, section on Antioxidants (2024)

Peer-Reviewed Study · National Cancer Institute, PDQ Cancer Information Summaries · April 5, 2024

National Cancer Institute et al., 2024-04-05: NCI's PDQ summary on supplement-drug interactions during cancer therapy. It states that evidence is insufficient for most antioxidant supplements and reports clinical studies associating antioxidant use during treatment with worse outcomes.

There is insufficient information for many specific antioxidant supplements to determine if they are safe and effective as a complementary therapy to standard cancer treatment.

Section 'Antioxidants – General Information'

National Cancer Institute et al., 2024-04-05: NCI's PDQ summary on supplement-drug interactions during cancer therapy. It states that evidence is insufficient for most antioxidant supplements and reports clinical studies associating antioxidant use during treatment with worse outcomes. Web-only PDQ summary, no PDF edition, hence empty pdf_url; the page's own footer gives Updated: April 5, 2024. Federal work: no funder/COI. Same section also summarises Jung et al. (Am J Clin Nutr 2019) and Ambrosone et al. (JCO 2020) as showing 'an increased risk of total mortality and worsened recurrence-free survival with antioxidant dietary supplement use during chemotherapy or radiation therapy'. NCI issues no recommendation to take antioxidants during treatment. Study type: review.